CTRI/2020/03/023947尚未招募未知
A randomized, double-blind, placebo-controlled, clinical study to evaluate the effect CUQ1720 on the postprandial response in healthy subjects and as an adjuvant to metformin in diabetic subjects.
Akay Flavours and Aromatics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. BMI of 18-30 kg/m2
排除标准
- •For Healthy Subjects
- •1. Fasting Blood Sugar < 110 mg/dl
- •2. Hb1Ac less than 5.7 %
- •For diabetic Subjects
- •1.Fasting Blood Sugar >= 120 to <= 150 mg/dl
- •2.Hb1Ac: Greater than 6.5 %
- •3.Subjects on metformin 500 mg, twice a day, since past 3 months
- •4.Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test at screening
- •5.Subject willing to adhere with their routine diet, physical activity, and general lifestyle throughout the study
- •6.Must be willing and able to give informed consent and comply with the study procedures.
研究者
相似试验
尚未招募
不适用
A clinical study to evaluate the safety and efficacy of ABE-0520 on middle-aged male subjects with androgen deficiencyCTRI/2021/01/030391Akay Natural Ingredients Pvt Ltd
进行中（未招募）
3 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus 2N(t)RTI in antiretroviral-naive HIV-infected individuals over 96 weeks. Encore1 intensive pharmacokinetics sub-studyHIV infectionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12612000263897Kirby Institute/University of New South Wales40
进行中（未招募）
1 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus two nucleotide reverse transcriptase inhibitors (N(t)RTI) in antiretroviral-naïve HIV-infected individuals over 96 weeks. - Encore1HIV infectionMedDRA version: 14.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestationsEUCTR2009-013795-44-GBational Centre in HIV Epidemiology and Clinical Research630
进行中（未招募）
3 期
A randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus two nucleotide reverse transcriptase inhibitors (N(t)RTI) in antiretroviral-naïve Human Immunodeficiency virus (HIV)-infected individuals over 96 weeks.HIV infectionInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12610001097033ational Centre for HIV Epidemiology and Clinical Research630
进行中（未招募）
不适用
A 96 week study comparing the standard dose (600mg) to the reduced dose (400mg) efavirenz with the combination of Truvada for HIV-infected participants who have not taken any anti-HIV medication.Human Immunodeficiency Virus infectionEUCTR2009-013795-44-DEThe Kirby Institute (formerly National Centre in HIV Epidemiology and Clinical Research (NCHECR)), University of New Sou630